Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

DP Veitch, MW Weiner, PS Aisen, LA Beckett… - Alzheimer's & …, 2019 - Elsevier
Introduction The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to
validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite …
被引用次数：415 相关文章

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

DP Veitch, MW Weiner, PS Aisen… - … & dementia: the …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to
validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite …

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.

DP Veitch, MW Weiner, PS Aisen… - … & Dementia: the …, 2018 - europepmc.org
Methods We used standard methods to identify nearly 600 publications using ADNI data
from 2016 and 2017 (listed in Supplementary Material and searchable at http://adni. loni …

[引用][C] Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

DP Veitch, MW Weiner, PS Aisen, LA Beckett… - Alzheimer's & …, 2018 - cir.nii.ac.jp
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent
highlights from the Alzheimer's Disease Neuroimaging Initiative | CiNii Research CiNii 国立 …

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

Alzheimer's Disease Neuroimaging … - Alzheimer's and …, 2019 - profiles.wustl.edu
Introduction: The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to
validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite …

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

… Disease Neuroimaging Initiative - Alzheimer's and …, 2019 - mayoclinic.elsevierpure.com
Introduction: The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to
validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite …

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

DP Veitch, MW Weiner, PS Aisen… - Alzheimer's & …, 2019 - Wiley Online Library
Introduction The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to
validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite …

[引用][C] Understanding disease progression and improving Alzheimer's disease clinical trials: recent highlights from the Alzheimer's disease neuroimaging initiative

DP Veitch - Alzheimers Dement, 2018 - cir.nii.ac.jp
Understanding disease progression and improving Alzheimer's disease clinical trials:
recent highlights from the Alzheimer's disease neuroimaging initiative | CiNii Research …